Entvin GTM brain

Entvin built AI tools for life sciences regulatory labeling and promotional review; its founder announced the company closed.

category

Life sciences regulatory AI

market profile

  • text: A founder has announced Entvin's closure, so historical product positioning should not be treated as a current offer.
  • text: Its documented products focused on label monitoring and promotional review rather than a verified end-to-end drug approval system.
  • text: The company announced $500,000 in funding in 2025 for pharmaceutical regulatory workflows.

personas

  • title: Head of regulatory affairs
    pains:
    • Label changes across regulators require continuous monitoring
    • Teams must review AI output against authoritative requirements
  • title: Regulatory labeling manager
    pains:
    • Comparing label versions and tracking competitor changes takes specialist time
    • An overlooked change may affect existing documentation
  • title: Medical, legal and regulatory promotional reviewer
    pains:
    • Promotional claims must match approved labels and applicable rules
    • Slow reviews can delay commercial material

icp

  • text: Pharmaceutical and biotech companies with FDA-facing regulatory and product labeling teams; size thresholds were not published.
  • text: Life sciences organizations with recurring promotional materials requiring medical, legal and regulatory review.

objections

  • objection: Is the company still operating?
    response: The founder announced closure; verify any current successor or support arrangement independently.
  • objection: Can AI review be trusted for regulated material?
    response: Require expert review and test traceability against approved labels and regulations.
  • objection: Can confidential product documents be shared safely?
    response: Assess security controls and contractual protections before sharing any material.

competitors

  • name: Veeva
    website: https://www.veeva.com/products/veeva-falcon-mlr/
    why: Offers AI review of life sciences promotional and medical content.
  • name: Yseop
    website: https://yseop.com/news-and-press-releases/yseop-joins-veevas-ai-partner-program-to-accelerate-regulatory-document-writing-and-ai-driven-content-automation/
    why: Automates regulatory document writing for life sciences.
  • name: EY Smart Reviewer
    website: https://www.ey.com/en_es/industries/life-sciences/smart-reviewer
    why: Reviews life sciences promotional materials against regulatory guidance.

influencers

  • name: Sanskar Jain
    url: https://www.linkedin.com/posts/sanskarjain_after-an-incredible-journey-weve-made-the-activity-7438781029366206464-VpRR
    why: Co-founder who announced the closure.

keywords

  • pharma labeling AI
  • FDA label change monitoring
  • promotional review AI
  • life sciences regulatory affairs automation
  • medical legal regulatory review
  • FDA compliance software

signals

  • text: A pharmaceutical team is tracking label revisions across multiple markets.
  • text: A growing volume of promotional material is creating review queues.

pricing

model: unknown

motion

unknown

channels

  • LinkedIn
  • press

confidence

low

Founders

  • name: Sanskar Jain
    title: Founder
    role: Founder
    bio: Sanskar is the Co-founder & CEO of Entvin, previously led Growth & Strategy at andMe (A D2C brand, acquired by GlobalBees). He was also an Analyst with A&M's Strategy and CDD practice in India. He has done Mechanical Engineering from IIT Bombay. He is passionate about innovations in Technology, Ecommerce, and Electric Vehicles.
  • name: Hemant Phalak
    title: Founder
    role: Founder
    bio: Hemant is the Co-founder & CPO of Entvin, previously he was founding team member at cross-border fintech Zolve. He was also an Associate at Pricewaterhousecoopers, India in the technology consulting practice. He has a B.Tech in Material sciences from IIT Bombay. His motto - 'Build what matters'

Back to YC companies